Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.65 |
| ▸ | MTOR | P42345 | 2/20 | 0.65 |
| ▸ | THRB | P10828 | 1/20 | 0.65 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.65 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.65 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.65 |
| ▸ | MAPT | P10636 | 1/20 | 0.55 |
| ▸ | CDA | P32320 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | GMNN | O75496 | 1/20 | 0.52 |
| ▸ | TP53 | P04637 | 1/20 | 0.52 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.52 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.52 |
| ▸ | THPO | P40225 | 1/20 | 0.52 |
| ▸ | HTT | P42858 | 1/20 | 0.52 |
| ▸ | RAB9A | P51151 | 1/20 | 0.52 |
| ▸ | BLM | P54132 | 1/20 | 0.52 |
| ▸ | HBB | P68871 | 1/20 | 0.52 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.52 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20967857 | 1.00 | LMNA (0.65) | LMNAMTORTHRBMDM2NCOA1 | |
| SCHEMBL20628772 | 1.00 | LMNA (0.65) | LMNAMTORTHRBMDM2NCOA1 | |
| SCHEMBL14946394 | 1.00 | LMNA (0.65) | LMNAMTORTHRBMDM2NCOA1 | |
| SCHEMBL20459954 | 1.00 | LMNA (0.65) | LMNAMTORTHRBMDM2NCOA1 | |
| SCHEMBL6397305 | 1.00 | LMNA (0.65) | LMNAMTORTHRBMDM2NCOA1 | |
| SCHEMBL14929347 | 1.00 | LMNA (0.65) | LMNAMTORTHRBMDM2NCOA1 | |
| SCHEMBL453447 | 1.00 | LMNA (0.65) | LMNAMTORTHRBMDM2NCOA1 | |
| Phosphoric Acid SCHEMBL15668496 | 0.96 | LMNA (0.60) | LMNAMTORTHRBMDM2NCOA1 | |
| Cytidine SCHEMBL15054404 | 0.94 | LMNA (0.77) | LMNAMTORTHRBMDM2NCOA1 | |
| SCHEMBL27056643 | 0.92 | LMNA (0.55) | LMNAMTORTHRBMDM2NCOA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 5333 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026103936-A1 | CHEMICALLY MODIFIED CIRCULAR RNA MOLECULE, PREPARATION METHOD THEREFOR, AND USE THEREOF | 上海元码智药生物技术有限公司 | 2026-05-21 | — | — | WO | claimed |
| US-20260139030-A1 | CHIMERIC PROTEINS FOR TREATING CUTANEOUS INFLAMMATION | SHATTUCK LABS INC (US) | 2026-05-21 | — | — | US | claimed |
| US-12618064-B2 | Acetylated ribonucleic acids and uses thereof | HELIX NANOTECHNOLOGIES INC (US) | 2026-05-05 | — | — | US | claimed |
| US-12584924-B2 | Compositions and methods for diagnosing and treating chronic kidney disease | SOCIETE DES PRODUITS NESTLE S.A. (CH) | 2026-03-24 | — | — | US | claimed |
| US-20260078413-A1 | METHODS AND PRODUCTS FOR EXPRESSING PROTEINS IN CELLS | FACTOR BIOSCIENCE INC (US) | 2026-03-19 | — | — | US | claimed |
| US-20260071215-A1 | SYSTEMS FOR ENHANCING TARGET MRNA EXPRESSION AND USES THEREOF | UNIV JOHNS HOPKINS (US) | 2026-03-12 | — | — | US | claimed |
| EP-4705481-A2 | CIRCULAR RNA COMPOSITIONS AND METHODS | Orna Therapeutics, Inc. (US) | 2026-03-11 | — | — | EP | claimed |
| EP-4705468-A1 | MAMMALIAN POLYCISTRONIC EXPRESSION SYSTEM FOR DIRECT TRANSLATION FROM RNA AND SECRETION OF CARGO | California Institute of Technology (US) | 2026-03-11 | — | — | EP | claimed |
| US-12551551-B2 | Compositions comprising α-factor prepro sequence and uses thereof | HELIX NANOTECHNOLOGIES INC (US) | 2026-02-17 | — | — | US | claimed |
| US-20260034204-A1 | RNA ENCODING VIRUS-LIKE PARTICLES AND USES THEREOF | SEQIRUS INC (US) | 2026-02-05 | — | — | US | claimed |
| CN-1297565-C | Method for preparing 2',3'2-dideoxycytidine | LU JINKANG (CN) | 2007-01-31 | — | — | CN | claimed |
| CN-1563030-A | Method for preparing 2',3'2-dideoxycytidine | LU JINKANG (CN) | 2005-01-12 | — | — | CN | claimed |
| US-20040110718-A1 | Anti-HCV nucleoside derivatives | DEVOS RENE (GB) | 2004-06-10 | — | — | US | claimed |
| CN-1466591-A | Nucleoside derivatives | - | 2004-01-07 | — | — | CN | claimed |
| WO-2002018404-A9 | NUCLEOSIDE DERIVATIVES FOR THE TREATMENT OF HEPATITIS C | HOFFMANN LA ROCHE (CH) | 2003-10-02 | — | — | WO | claimed |
| EP-1315736-A2 | NUCLEOSIDE DERIVATIVES FOR THE TREATMENT OF HEPATITIS C | F. HOFFMANN-LA ROCHE AG (CH) | 2003-06-04 | — | — | EP | claimed |
| US-20030007961-A1 | Orthomolecular vitamin E derivatives | WILBURN MICHAEL D (US) | 2003-01-09 | — | — | US | claimed |
| US-20030008841-A1 | Anti-HCV nucleoside derivatives | F. HOFFMAN-LA ROCHE, A SWISS COMPANY (CH) | 2003-01-09 | — | — | US | claimed |
| US-6365374-B1 | NUCLEOTIDE STABILIZES RIBOZYMES AND ANTISENSE OLIGONUCLEOTIDES | RIBOZYME PHARMACEUTICALS, INC. | 2002-04-02 | — | — | US | claimed |
| WO-2002018404-A2 | NUCLEOSIDE DERIVATIVES FOR THE TREATMENT OF HEPATITIS C | F. HOFFMANN-LA ROCHE AG (CH) | 2002-03-07 | — | — | WO | claimed |